Visual performance in giant cell arteritis (temporal arteritis) after 1 year of therapy Academic Article Article uri icon

Overview

MeSH Major

  • Antirheumatic Agents
  • Arthritis, Rheumatoid
  • Arthroplasty
  • Postoperative Complications

abstract

  • Patients with GCA related visual loss can improve with treatment. Corticosteroids with starting doses of 60-1000 mg per day, with reduction to daily doses of 40-50 mg per day given for 4-6 weeks, and gradual dose reduction thereafter, as clinically permitted, did not result in delayed visual loss. There were no significant drug related ophthalmic complications.

publication date

  • January 1999

Research

keywords

  • Academic Article

Identity

PubMed ID

  • 10381666

Additional Document Info

start page

  • 796

end page

  • 801

volume

  • 83

number

  • 7